(Q43818110)

27 November 2017

Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapy (English)

1 reference

27 November 2017

Lafeuillade A

1

1 reference

27 November 2017

Poggi C

2

1 reference

27 November 2017

Chadapaud S

3

1 reference

27 November 2017

Hittinger G

4

1 reference

27 November 2017

Khiri H

5

1 reference

27 November 2017

Halfon P

6

1 reference

27 November 2017

1 July 2001

1 reference

27 November 2017

1 reference

27 November 2017

2

1 reference

27 November 2017

3

1 reference

27 November 2017

189-194

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

27 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Dynamics of Provirus Load and Lymphocyte Subsets after Interleukin 2 Treatment in HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with 500 × 106/l CD4 cells treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00065.X

10.1046/J.1468-1293.2001.00065.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference